Early Combination Therapy in Type 2 Diabetes (vol 15, pg 478, 2019)

被引：0

作者：

Kahl, Sabine ^{[1
]}

机构：

[1] Heinrich Heine Univ, Inst Klin Diabetol, Deutsch Diabet Zentrum, Leibniz Zentrum Diabet Forsch, Aufm Hennekamp 65, D-40225 Dusseldorf, Germany

来源：

DIABETOLOGE | 2019年 / 15卷 / 05期

关键词：

D O I：

10.1007/s11428-019-0501-9

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Erratum zu:Der Diabetologe 201910.1007/s11428-019-0452-1In diesem Beitrag bitten wir darum, folgende prazisierten Angaben bezuglich der Darstellung des Ausgangs-HbA(1c) (HbA(1c): Glykohamoglobin Typ A(1c)) einer Studiensubgruppe zu beachten:Der Anteil von Studienteilnehmern mit einem HbA(HbA) ...

引用

页码：478 / 478

页数：1

共 50 条

[41] Combination therapy for patients with Type 2 diabetes: repaglinide in combination with metformin
Moses, Robert G.
[J]. EXPERT REVIEW OF ENDOCRINOLOGY & METABOLISM, 2010, 5 (03) : 331 - 342
[42] The Burmese cat as a genetic model of type 2 diabetes in humans (vol 50, pg 319, 2019)
Samaha
[J]. ANIMAL GENETICS, 2020, 51 (01) : 153 - 153
[43] Heart failure: A preventable and treatable complication of type 2 diabetes (vol 11, pg 613, 2019)
Straw, S.
Witte, K. K.
Kearney, M. T.
[J]. JOURNAL OF DIABETES, 2020, 12 (08) : 626 - 626
[44] Early therapy for type 2 diabetes in China
Yang, Wenying
Weng, Jianping
[J]. LANCET DIABETES & ENDOCRINOLOGY, 2014, 2 (12): : 992 - 1002
[45] The early combined therapy by type 2 diabetes
Ametov, A. S.
Karpova, E. V.
[J]. DIABETES MELLITUS, 2011, 14 (03): : 80 - 83
[46] Initial Combination of Empagliflozin and Linagliptin in Subjects With Type 2 Diabetes (vol 38, pg 394, 2015)
Lewin, Andrew
DeFronzo, Ralph A.
Patel, Sanjay
Liu, Dacheng
Kaste, Renee
Woerle, Hans J.
Broedl, Uli C.
[J]. DIABETES CARE, 2015, 38 (06)
[47] SGLT2 Inhibitors in Combination Therapy: From Mechanisms to Clinical Considerations in Type 2 Diabetes Management (vol 41, pg 1543, 2018)
van Baar, Michael J. B.
van Ruiten, Charlotte C.
Muskiet, Marcel H. A.
van Bloemendaal, Liselotte
IJzerman, Richard G.
van Raalte, Daniel H.
[J]. DIABETES CARE, 2019, 42 (10) : 2015 - 2015
[48] Early combination therapy with pioglitazone reveals the highest benefits in patients with type 2 diabetes mellitus
Axmann, C
Lübben, G
[J]. DIABETOLOGIA, 2005, 48 : A279 - A279
[49] Effect of type 2 diabetes mellitus caveolin-3 K15N mutation on glycometabolism (vol 18, pg 2531, 2019)
Huang, Yiyuan
Deng, Yufeng
Shang, Lina
Yang, Lihui
Huang, Juanjuan
Ma, Jing
Liao, Xianshan
Zhou, Hui
Xian, Jing
Liang, Guining
Huang, Qin
[J]. EXPERIMENTAL AND THERAPEUTIC MEDICINE, 2020, 19 (02) : 1137 - 1137
[50] Polysaccharide Peptide (PsP) Ganoderma lucidum: A Potential Inducer For Vascular Repair In Type 2 Diabetes Mellitus Model (vol 15, pg 419, 2019)
Heriansyah, T.
Nurwidyaningtyas, W.
Sargowo, D.
Tjahjono, C. T.
Wihastuti, T. A.
[J]. VASCULAR HEALTH AND RISK MANAGEMENT, 2019, 15 : 517 - 517

← 1 2 3 4 5 →